Concepedia

Feng Yang

FY

Statistics

Publications

8

Citations

291

H-Index

8

Active since

2015

Affiliations

Regeneron (United States)(Current)

Feng Yang is an author at Regeneron (United States) specializing in pharmacy, pharmacology, and pharmacokinetics of monoclonal antibodies.

ORCID

Publications per year

2015–2021

8

Publications

8

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants

Eric A. F. Simões, Eduardo Forleo‐Neto, Gregory P. Geba et al. · Clinical Infectious Diseases · 2020 · 156 citations · Full text

, , +14

A first‐in‐human pharmacodynamic and pharmacokinetic study of a fully human anti‐glucagon receptor monoclonal antibody in normal healthy volunteers

Ana Kostić, Thomas Alexander King, Feng Yang et al. · Diabetes Obesity and Metabolism · 2017 · 35 citations · Full text

, , +17

Population pharmacokinetic characteristics of cemiplimab in patients with advanced malignancies

Feng Yang, Anne Paccaly, Ronda Rippley et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2021 · 28 citations · Full text

, , +16

Phase 1 Study Evaluating Safety, Tolerability, Pharmacokinetics and Immunogenicity of REGN2222 in Healthy Adults: A New Human Monoclonal RSV-F Antibody for RSV Prevention

Sumathi Sivapalasingam, David Caballero-Perez, Matthew C. Houghton et al. · Open Forum Infectious Diseases · 2015 · 19 citations · Full text

, , +13

Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment

Robert Dufour, Jean Bergeron, Daniel Gaudet et al. · International Journal of Cardiology · 2016 · 19 citations · Full text

, , +16

1–5 of 8